"Masimo secures FDA approval for OIRD detection on wearable patient monitor" was originally created and published by Medical ...

The OIRD detection capability [Image courtesy of Masimo] Masimo, a Danaher (NYSE:DHR) company, today announced FDA clearance for an opioid-induced respiratory depression (OIRD) detection platform.

This review synthesised existing evidence on racial disparities in pulse oximeter accuracy, quantified the degree of bias, evaluated clinical effects, highlighted implications for practice, and ...

All right. Good morning, everyone, and welcome to Masimo's 2025 Investor Day. I'm Matt Brinckman. I recently joined Masimo as Senior Vice President of FP&A and Investor Relations. I've been working ...

Performance listed in the above table is net of annual operating expenses. The gross annual expense ratio for the Retail Shares and Institutional Shares as of April 26, 2024 was 1.20% and 0.88%, ...

What Is a Pulse Oximeter? A pulse oximeter, or pulse ox, is an electronic device that can be attached to your forehead, fingers, nose, foot, toes, or ears. A nurse or medical assistant usually clamps ...

The recall began earlier this year after GE HealthCare learned that some of its TruSignal SpO2 sensors may be at risk of malfunctioning, which the FDA has linked to flaws in the design of the devices.

The resistance created by the PEEP-valve of a T-piece resuscitator is bias gas flow dependent and might affect breathing in preterm infants. In this study we investigated the effect of a higher bias ...